🔴 Senti Biosciences is trading 16.21% down in after-hours trading with no clear company-specific catalyst

Senti Biosciences is trading 16.21% lower at $0.29 in after-hours trading, with no clear company-specific catalyst identified.

• The stock closed at $0.34 on September 24, 2026. Recent filings concern a proposed Celadon-affiliated transaction, potential milestone-based CVRs, and securities-registration activity, but do not directly explain the decline.
• The Nasdaq Composite was down 1.07%; the stock’s drop appears primarily speculative and liquidity-driven.